Paller A, Silverberg J, Hong HC ho, Cork M, Puig L, Arlert P, Kurbasic A, Soldbro L, Simpson E. The impact of tralokinumab on quality of life and school in patients aged 12-17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s139. Available from: https://jofskin.org/33014/index.php/skin/article/view/2026